About the Authors
- Dagmar von Bubnoff
-
Contributed equally to this work with: Dagmar von Bubnoff, Christina Schmitt
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Validation, Writing – original draft, Writing – review & editing
Affiliation Department of Dermatology, University Hospital Lübeck, Lübeck, Germany
- Christina Schmitt
-
Contributed equally to this work with: Dagmar von Bubnoff, Christina Schmitt
Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
- Simone M. Goldinger
-
Roles Data curation, Investigation, Validation, Writing – review & editing
Affiliation Department of Dermatology, University Hospital of Zurich, Zürich, Switzerland
- Dirk Schadendorf
-
Roles Data curation, Investigation, Validation, Writing – review & editing
Affiliation Department of Dermatology, University Hospital Essen, Essen, Germany
- Katharina C. Kähler
-
Roles Data curation, Investigation, Validation, Writing – review & editing
Affiliation Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
- Christian Hafner
-
Roles Data curation, Investigation, Validation, Writing – review & editing
Address: Dermatohistologie am Stachus, Munich, Germany
Affiliation Department of Dermatology, University Hospital Regensburg, Regensburg, Germany
- Nora Kramer
-
Roles Data curation, Investigation, Validation, Writing – review & editing
Affiliation Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
- Waltraud Fröhlich
-
Roles Data curation, Investigation, Validation, Writing – review & editing
Affiliations Department of Dermatology, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany, Deutsches Zentrum Immuntherapie, Erlangen, Germany
- Reinhard Dummer
-
Roles Data curation, Investigation, Validation, Writing – review & editing
Affiliation Department of Dermatology, University Hospital of Zurich, Zürich, Switzerland
- Carola Berking
-
Roles Data curation, Investigation, Resources, Validation, Writing – original draft, Writing – review & editing
Affiliations Department of Dermatology, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany, Deutsches Zentrum Immuntherapie, Erlangen, Germany
- Stefan Schliep
-
Roles Data curation, Investigation, Validation, Writing – review & editing
Affiliations Department of Dermatology, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany, Deutsches Zentrum Immuntherapie, Erlangen, Germany
- Michael C. Kirchberger
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Address: Hautarztzentrum Ingolstadt, Ingolstadt, Germany
Affiliations Department of Dermatology, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany, Deutsches Zentrum Immuntherapie, Erlangen, Germany
- Lucie Heinzerling
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: lucie.heinzerling@med.uni-muenchen.de
Affiliations Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany, Department of Dermatology, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany, Deutsches Zentrum Immuntherapie, Erlangen, Germany
Competing Interests
I have read the journal's policy and the authors of this article have the following competing interests: DS reports personal fees and non-financial support from Roche/Genentech, grants, personal fees, non-financial support and other from Novartis, grants, personal fees, non-financial support and other from BMS, personal fees and non-financial support from Merck Serono, grants, personal fees and non-financial support from Amgen, personal fees from Immunocore, Incyte, 4SC, Pierre Fabre, Sanofi/Regeneron, non-financial support from Merck, personal fees from Array BioPharma, Pfizer, Philogen, Regeneron, Nektar, Sunpharma, grants, personal fees and non-financial support from MSD, outside the submitted work. DS received personal fees from Anaveon, AstraZeneca, BioAlta, BioNTech, BMS, CureVac, Daiichi Sanyko, Erasca, Formycon, Immatics, Immunocore, InFlarX, Merck Serono, MSD, Neracare, Novartis, NoviGenix, PamGene, Pfizer, Philogen, Pierre Fabre, Replimune, Sanofi/Regeneron, Seagen, SunPharma, Ultimovacs. DS declares personal and institutional support from BMS, MSD, Novartis, Philogen, Pierre Fabre, Sanofi. DS is a Member of Board of Directors of the EORTC-MG and Founding member and SC chair of the European Melanoma Registry (EuMelaReg). KCK serves as consultant to Philogen, BMS, MSD, Sanofi Aventis, Immunocore and received travel grants and speaker fees from Philogen, Pierre Fabre, BMS, MSD, Sun Pharma, Sanofi Aventis, Novartis, Medac and has received research support by Novartis. CH received support from BMS. NK received travel support from Sun Pharma. RD has intermittent, project focused consulting and/or advisory relationships with Novartis, Merck Sharp & Dhome (MSD), Bristol-Myers Squibb (BMS), Roche, Amgen, Takeda, Pierre Fabre, Sun Pharma, Sanofi, Catalym, Second Genome, Regeneron, Alligator, T3 Pharma, MaxiVAX SA, Pfizer, Simcere and touchIME outside the submitted work. CB has received advisory board/consultancy fees and/or speaker´s fees from BMS, Delcath, Immunocore, InflaRx, Miltenyi, MSD, Novartis, Regeneron, Sanofi, and Pierre Fabre. LH has received speaker and consultancy fees from BMS, Immunocore, Kyowa Kirin, Mallinckrodt, MSD, Novartis, Pieris, Pierre Fabre, Therakos (UK) LTD and SUN. The institution received research grants or clinical study grants from Agenus, AstraZeneca Inc., BMS, Huya Bioscience, Immunocore, IO Biotech, Merck, Pfizer, Pierre Fabre, Regeneron, Replimune and Sanofi Aventis. All remaining authors have declared no conflicts of interest. The competing interests do not alter our adherence to PLOS One policies on sharing data and materials.